News

News

News

Stay up to date with our latest news and announcements.

Ardena’s New State-of-the-Art Nanomedicine Facility Secures Full GMP Approval for Manufacturing

Ardena’s New State-of-the-Art Nanomedicine Facility Secures Full GMP Approval for Manufacturing

Showing 6 out of 14 results

Ardena Strengthens Executive Leadership With Appointments of Chief Quality Officer and Chief Information Officer

Ardena Strengthens Executive Leadership With Appointments of Chief Quality Officer and Chief Information Officer

Peptinovo Chooses Ardena to Manufacture Novel Cancer Nanotherapy

Peptinovo Chooses Ardena to Manufacture Novel Cancer Nanotherapy

Ardena and MAXONA Pharmaceuticals Announce Collaboration for Development of MAX-001 Program

Ardena and MAXONA Pharmaceuticals Announce Collaboration for Development of MAX-001 Program

Ardena Supports Topas Therapeutics' Nanoparticle-Based Immune Tolerance Therapies Advancing to Clinical Development

Ardena Supports Topas Therapeutics' Nanoparticle-Based Immune Tolerance Therapies Advancing to Clinical Development

Ardena Completes Acquisition of Advanced Drug Product Manufacturing Facility from Catalent and Expands Bioanalytical Services in North America

Ardena Completes Acquisition of Advanced Drug Product Manufacturing Facility from Catalent and Expands Bioanalytical Services in North America

Ardena’s New State-of-the-Art Nanomedicine Facility Secures Full GMP Approval for Manufacturing

Ardena’s New State-of-the-Art Nanomedicine Facility Secures Full GMP Approval for Manufacturing

Load more

Explore our tailored nanomedicine solutions

Contact us to discuss your nanomedicine project with our experts

Get in touch